Xiali Tang

688 total citations
14 papers, 547 citations indexed

About

Xiali Tang is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Xiali Tang has authored 14 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Xiali Tang's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (5 papers) and Liver physiology and pathology (4 papers). Xiali Tang is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (5 papers) and Liver physiology and pathology (4 papers). Xiali Tang collaborates with scholars based in China and United States. Xiali Tang's co-authors include Demin Jiao, Qingyong Chen, Jun Chen, Wei Lu, Huizhen Hu, Jian Wang, Jia Song, Jian Wang, Jian Wang and Wei Xu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Experimental Biology and Medicine and Oncotarget.

In The Last Decade

Xiali Tang

14 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiali Tang China	10	370	262	97	58	51	14	547
Yingchun He China	11	296 0.8×	149 0.6×	76 0.8×	47 0.8×	38 0.7×	35	493
AmirReza Hesari Iran	13	315 0.9×	163 0.6×	92 0.9×	35 0.6×	31 0.6×	17	530
Weiwei Shao China	15	424 1.1×	165 0.6×	112 1.2×	79 1.4×	23 0.5×	38	675
Jiapeng Xu China	11	279 0.8×	135 0.5×	64 0.7×	57 1.0×	48 0.9×	24	438
Liying Wu China	13	323 0.9×	191 0.7×	102 1.1×	45 0.8×	31 0.6×	23	520
Darko Castven Germany	10	229 0.6×	114 0.4×	106 1.1×	28 0.5×	43 0.8×	22	425
Pihong Li China	12	243 0.7×	107 0.4×	86 0.9×	61 1.1×	41 0.8×	23	456
Huiying Chi China	11	446 1.2×	298 1.1×	52 0.5×	24 0.4×	46 0.9×	15	696
Chunjie Wen China	15	316 0.9×	162 0.6×	105 1.1×	48 0.8×	39 0.8×	29	519
Hamid Fiuji Iran	17	419 1.1×	248 0.9×	218 2.2×	87 1.5×	58 1.1×	44	686

Countries citing papers authored by Xiali Tang

Since Specialization

Citations

This map shows the geographic impact of Xiali Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiali Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiali Tang more than expected).

Fields of papers citing papers by Xiali Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiali Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiali Tang. The network helps show where Xiali Tang may publish in the future.

Co-authorship network of co-authors of Xiali Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiali Tang. A scholar is included among the top collaborators of Xiali Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiali Tang. Xiali Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Tang, Xiali, Yu Chen, Demin Jiao, et al.. (2023). Tumor-associated Macrophages Mediate Gefitinib Resistance in Lung Cancerthrough HGF/c-met Signaling Pathway. Anti-Cancer Agents in Medicinal Chemistry. 24(1). 30–38. 3 indexed citations

Jiao, Demin, Yu Chen, Xiang Liu, et al.. (2023). Targeting MET endocytosis or degradation to overcome HGF-induced gefitinib resistance in EGFR-sensitive mutant lung adenocarcinoma. Biochemical and Biophysical Research Communications. 682. 371–380. 2 indexed citations

Luo, Xi, et al.. (2022). [LINC01285 promotes proliferation and metastasis of colorectal cancer cells by regulating epithelial-mesenchymal transition].. PubMed. 42(11). 1697–1704. 1 indexed citations

Liu, Xiang, Demin Jiao, Xiali Tang, et al.. (2021). Epidemiologic Characteristics of and Prognostic Factors for COVID-19 Among Hospitalized Patients: Updated Implications From Hubei Province, China. Frontiers in Public Health. 9. 726491–726491. 1 indexed citations

Tang, Xiali, Ying Zheng, Demin Jiao, et al.. (2020). Anlotinib Inhibits Cell Proliferation, Migration and Invasion via Suppression of c-Met Pathway and Activation of ERK1/2 Pathway in H446 Cells. Anti-Cancer Agents in Medicinal Chemistry. 21(6). 747–755. 9 indexed citations

Chen, Jun, et al.. (2019). Mogroside V Inhibits Hyperglycemia-induced Lung Cancer Cells Metastasis through Reversing EMT and Damaging Cytoskeleton. Current Cancer Drug Targets. 19(11). 885–895. 29 indexed citations

Jiao, Demin, Jun Chen, Yumin Li, et al.. (2018). miR‐1‐3p and miR‐206 sensitizes HGF‐induced gefitinib‐resistant human lung cancer cells through inhibition of c‐Met signalling and EMT. Journal of Cellular and Molecular Medicine. 22(7). 3526–3536. 70 indexed citations

Tang, Xiali, Yan Li, Ling Zhu, et al.. (2017). Salvianolic acid A reverses cisplatin resistance in lung cancer A549 cells by targeting c-met and attenuating Akt/mTOR pathway. Journal of Pharmacological Sciences. 135(1). 1–7. 50 indexed citations

Chen, Qingyong, Demin Jiao, Jian Wang, et al.. (2016). miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET. Oncotarget. 7(17). 24510–24526. 87 indexed citations

10.

Chen, Qingyong, Huizhen Hu, Demin Jiao, et al.. (2016). miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: The underlying molecular mechanisms. Oncology Reports. 36(2). 909–917. 27 indexed citations

11.

Jiao, Demin, Jian Wang, Wei Lu, et al.. (2016). Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways in lung cancer. Molecular Therapy — Oncolytics. 3. 16018–16018. 142 indexed citations

12.

Chen, Qingyong, Demin Jiao, Yuquan Wu, et al.. (2016). MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Oncotarget. 7(14). 18247–18261. 96 indexed citations

13.

Li, Yan, Demin Jiao, Huizhen Hu, et al.. (2016). Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach. Experimental Biology and Medicine. 242(7). 709–717. 18 indexed citations

14.

Chen, Qingyong, Demin Jiao, Huizhen Hu, et al.. (2015). Identification of carcinogenic potential-associated molecular mechanisms in CD133+ A549 cells based on microRNA profiles. Tumor Biology. 37(1). 521–530. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact